The merger will create a specialty company, REGiMMUNE/Kiji TX, for regulatory T cells.
REGiMMUNE and Kiji Therapeutics to Merge
The merger will create a specialty company, REGiMMUNE/Kiji TX, for regulatory T cells.
The merger will create a specialty company, REGiMMUNE/Kiji TX, for regulatory T cells.
The merger will create a specialty company, REGiMMUNE/Kiji TX, for regulatory T cells.